We provide you with 20 years of free, institutional-grade data for CALA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CALA. Explore the full financial landscape of CALA stock.
| Reported Date | CIK | Ticker | Type |
|---|
Calithera Biosciences, Inc(NASDAQ:CALA) 
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Its lead product candidate is CB-839, an inhibit...
Website: http://www.calithera.com
Founded: 2010
Full Time Employees: 92 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about CALA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.